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Patients that survive hemorrhage and resuscitation (H/R) may develop a systemic inﬂammatory response syndrome (SIRS) that
leads to dysfunction of vital organs (multiple organ dysfunction syndrome, MODS). SIRS and MODS may involve mitochondrial
dysfunction. Under pentobarbital anesthesia, C57BL6 mice were hemorrhaged to 30mmHg for 3h and then resuscitated with
shed blood plus half the volume of lactated Ringer’s solution containing minocycline, tetracycline (both 10mg/kg body weight)
or vehicle. Serum alanine aminotransferase (ALT), necrosis, apoptosis and oxidative stress were assessed 6 h after resuscitation.
Mitochondrialpolarizationwasassessedbyintravitalmicroscopy.AfterH/Rwithvehicleortetracycline,ALTincreasedto4538U/L
and 3999U/L, respectively, which minocycline decreased to 1763U/L (P<0.01). Necrosis and TUNEL also decreased from 24.5%
and 17.7 cells/ﬁeld, respectively, after vehicle to 8.3% and 8.7 cells/ﬁeld after minocycline. Tetracycline failed to decrease necrosis
(23.3%) but decreased apoptosis to 9 cells/ﬁeld (P<0.05). Minocycline and tetracycline also decreased caspase-3 activity in
liver homogenates. Minocycline but not tetracycline decreased lipid peroxidation after resuscitation by 70% (P<0.05). Intravital
microscopy showed that minocycline preserved mitochondrial polarization after H/R (P<0.05). In conclusion, minocycline
decreases liver injury and oxidative stress after H/R by preventing mitochondrial dysfunction.
1.Introduction
Trauma and surgical procedures, including gastrointestinal
andhepatobiliarysurgery,canleadtoseverehemorrhageand
hypovolemic shock. Fluid resuscitation after less than one
hour of severe hemorrhagic shock restores hemodynamics
and typically leads to full recovery. By contrast although
restoring hemodynamics, resuscitation after greater than
an hour may lead instead to multiple organ dysfunction
syndrome (MODS), which is associated with mortality of
30% [1]. Eﬀective strategies to extend this golden hour for
resuscitation are therefore needed to improve the treatment
of hemorrhagic shock and decrease the incidence of MODS
and its lethal consequence. Hemorrhage/resuscitation
(H/R) is an example of ischemia/reperfusion (I/R) and
hypoxia/reoxygenation injuries, for which mitochondrial
dysfunction plays a major pathophysiological role [2–
4]. Moreover, the liver with its crucial involvement in
metabolism and homeostasis is among the most frequently
aﬀected organs after hemorrhage-induced hypotension in
humans [5].
I/R injury leads to both necrotic cell death and apoptosis.
A common pathway for hepatic apoptosis and necrosis
after I/R is the mitochondrial permeability transition (MPT)
[6]. Opening of permeability transition (PT) pores in
the mitochondrial inner membrane causes the MPT with2 HPB Surgery
consequent mitochondrial depolarization and uncoupling of
oxidative phosphorylation. ATP depletion after uncoupling
produces necrotic cell killing, the main pathway of cell
death after I/R, whereas cytochrome c release due to MPT-
driven mitochondrial swelling induces caspase-dependent
apoptosis. Previously, experimental strategies to inhibit the
MPTafterlivertransplantationinratsimprovedsurvivaland
decreased mitochondrial dysfunction [7].
Minocycline is a semisynthetic tetracycline antibiotic,
which is protective against neurodegenerative disease,
trauma,andhypoxia/ischemia[8–12].Mechanismsbywhich
minocycline exerts neuroprotection include inhibition of
apoptotic pathways, decreased mitochondrial release of
proapoptotic factors like cytochrome c, and upregulation
of antiapoptotic Bcl-2 and inhibitor of apoptosis pro-
teins (IAPs) [13, 14]. In orthotopic rat liver transplanta-
tion, minocycline cytoprotection against storage/reperfusion
injury is mediated by suppression of the MPT through
inhibition of the mitochondrial calcium uniporter [7]. Here,
we investigated whether resuscitation with minocycline also
decreases liver injury after H/R.
2.MaterialsandMethods
2.1. Chemicals and Reagents. Minocycline, tetracycline, rho-
damine 123, and other reagents were purchased from Sigma-
Aldrich (St. Louis, MO).
2.2. Animals. Male C57BL/6J mice (8–10wk of age, 23–27g)
were obtained from Jackson Laboratory (Bar Harbor, ME).
Animal protocols were approved by the Institutional Animal
Care and Use Committee of the Medical University of South
Carolina.
2.3.HemorrhagicShockandResuscitation. Afteranovernight
fast, mice were anesthetized with pentobarbital sodium
(80mg/kgbodyweight). Under spontaneous breathing,
both femoral arteries were exposed and cannulated with
polyethylene-10 catheters (SIMS Portex). The catheters
were ﬂushed with normal saline containing heparin
(100IU/l) before insertion. One catheter was connected via
a transducer to a pressure analyzer (Micro-Med; Louisville,
KY), and blood was withdrawn via the second catheter into a
heparinized syringe (10units) over 5min to a mean arterial
pressure of 30mmHg. This pressure was maintained for
3h by withdrawal or reinfusion of shed blood [15]. Body
temperature was monitored and maintained at 37◦C. After
3h, mice were resuscitated with a syringe pump over 30min
with shed blood followed by a volume of lactated Ringer’s
solution corresponding to 50% of the shed blood volume
[16, 17]. As indicated, the resuscitating Ringer’s solution
contained minocycline (10mg/kgbodyweight), tetracycline
(10mg/kg), orvehicle. Doses ofminocycline and tetracycline
were based on a prior study [7]. Adequacy of resuscitation
was determined by the restoration of blood pressure.
Catheters were then removed, the vessels were ligated, and
the groin incisions were closed. Sham-operated animals
underwent the same surgical procedures, but hemorrhage
was not carried out. No mortality in any group occurred
over the course of the experiments.
For the determination of hemorrhage-/resuscitation-
dependent liver damage, mice were anesthetized and killed
by exsanguination 6h after the end of resuscitation. For each
mouse, the two right dorsal liver lobes were snap-frozen in
liquidnitrogen.Theremainingliverwasﬂushedwithnormal
saline, infused and ﬁxed with 4% buﬀered paraformaldehyde
through the portal vein, and embedded in paraﬃns e c t i o n s .
2.4. Alanine Aminotransferase (ALT). Blood samples to mea-
sure ALT were collected from the inferior vena cava 6h after
H/R for analysis by standard methods.
2.5. Histology. Sections (4µm) were stained with hema-
toxylinandeosin(H&E).Tenrandomﬁeldswereassessedfor
necrosis by standard morphologic criteria (e.g., loss of archi-
tecture, vacuolization, karyolysis, increased eosinophilia).
Images were captured by an image analysis system (Olympus
BH-2 Microscope; Micropublisher 5.0 RTV, Center Valley,
PA), and the area percentage of necrosis was quantiﬁed using
a computer program (BioQuant BQ Nova Prime 6.7, R&M
Biometrics, Nashville, TN).
2.6. TUNEL. Terminal deoxynucleotidyl transferase-medi-
ated dUTP nick-end labeling (TUNEL) was performed on
paraﬃn sections using an in situ cell death detection kit
(Roche Diagnostics, Penzberg, Germany). TUNEL-positive
cells were counted by light microscopy in 10 random high-
power ﬁelds (HPF).
2.7. Caspase-3. Liver tissue (∼100mg) was homogenized
(Polytron PT-MR2100, Kinematica, Luzern, Switzerland) in
1mL of lysis buﬀer containing 0.1% 3[(3-cholamidopro-
pyl)dimethylammonio]-propanesulfonic acid, 2mM EDTA,
5mM dithiothreitol, 1mM Pefabloc, 10ng/mL pepstatin A,
10ng/mL aprotinin, 20µg/mL leupeptin, and 10mM HEPES
buﬀer, pH 7.4. The lysate was centrifuged at 15,000rpm
for 30min. Activity of caspase-3 in the supernatant was
determined using a Caspase-3 Colorimetric Assay Kit (R&D
Systems, Minneapolis, MN) according to the manufacturer’s
instructions. Activity was normalized to protein concentra-
tion of each sample and expressed as fold increase compared
to sham.
2.8. 4-Hydroxynonenal. Paraﬃn-embedded sections were
deparaﬃnized, rehydrated, and incubated with polyclonal
antibodies against 4-hydroxynonenal (4-HNE, Alpha Diag-
nostics; San Antonio, TX) in PBS (pH 7.4) containing
1% Tween 20 and 1% bovine serum albumin. Peroxidase-
linked secondary antibody and diaminobenzidine (Perox-
idase Envision Kit, DAKO) were used to detect speciﬁc
binding. A Universal Imaging Metamorph image acquisition
and analysis system (Chester, PA) incorporating an Axioskop
50 microscope (Carl Zeiss; Thornwood, NY) was used to
capture and analyze the immunostained tissue sections at
40x magniﬁcation. The extent of labeling was determined
in randomly selected ﬁelds as the percentage of area withinHPB Surgery 3
a preset color range determined by the software. Data
from each tissue section (10 ﬁelds/section) were pooled to
determine means, as described previously [18].
2.9. Intravital Multiphoton Microscopy. At 4h after H/R,
mice were anesthetized with pentobarbital (50mg/kg) and
connected to a small animal ventilator via a tracheostomy
and respiratory tube (22-gauge catheter), as described previ-
ously [19]. Laparotomy was performed, and a polyethylene-
10 catheter was inserted into the distal part of the right colic
vein.Usingasyringepump,rhodamine123(1µmol/mouse),
a membrane potential-indicating ﬂuorophore, was infused
via the catheter over 10min. After prone positioning of the
mouse, the liver was gently withdrawn from the abdominal
cavity and placed over a glass coverslip on the microscope
stage. Rhodamine 123 ﬂuorescence was excited with 820nm
light from a Chameleon Ultra Ti-Sapphire pulsed laser
(Coherent, Santa Clara, CA) and imaged with a Zeiss LSM
510 NLO inverted laser scanning confocal microscope using
a 63x 1.3 NA water-immersion objective lens. Green rho-
damine123ﬂuorescencewascollectedthrougha525±25nm
band pass ﬁlter. During image acquisition, the respirator
was turned oﬀ for ∼5sec to eliminate movement artifacts
from breathing. In 20 ﬁelds per liver, parenchymal cells
were scored for bright punctate rhodamine 123 ﬂuorescence
representing hepatocytes with polarized mitochondria or
dimmer diﬀuse cytosolic ﬂuorescence representing hepato-
cytes with depolarized mitochondria. Image analysis was
performed in a blinded fashion.
2.10. Statistical Analysis. Data are presented as means ±S.E.,
unless otherwise noted. Statistical analysis was performed
by ANOVA plus Student-Newman-Keuls test, as appropriate,
using P<0.05 as the criterion of signiﬁcance.
3. Results
3.1. Decreased ALT Release and Liver Necrosis after Resuscita-
tion with Minocycline. C57BL6 mice were hemorrhaged for
3h and resuscitated with shed blood followed by half the
volume of lactated Ringer solution, containing minocycline
(10mg/kg), tetracycline (10mg/kg), or vehicle. As described
previously [20], resuscitation restored mean arterial pressure
to ∼80mmHg, which was nearly identical to blood pressure
before hemorrhage (data not shown). At 6h postoperatively,
sham-operated mice had serum ALT of 105±15U/L (Figure
1). After H/R, ALT after vehicle treatment increased to
4538U/L±557U/L, which decreased to 1763 ± 213U/L
after resuscitation with minocycline (P<0.01). Identical
treatment with tetracycline did not cause a statistically
signiﬁcant change of serum ALT (3999±491U/L) compared
to vehicle (Figure 1).
Liver injury was also assessed histologically at 6h
postoperatively. In sham-operated mice, liver histology
was normal and indistinguishable from untreated mice
(Figure 2(a)anddatanotshown).AfterH/Rwithvehicleand
tetracycline treatments, large areas of necrosis developed 6h
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Figure 1: Minocycline decreases ALT release after hemorrhage and
resuscitation. Mice were resuscitated with shed blood and then
half the volume of lactated Ringer’s solution containing tetracycline
or minocycline (10mg/kgbodyweight) or vehicle, as described
in materials and methods. Serum ALT was assessed 6h after
resuscitation. Group sizes were sham, 4; vehicle, 7; minocycline, 7;
tetracycline, 7. ∗P<0.01 versus vehicle and tetracycline.
postoperatively with a predominately pericentral and mid-
zonal distribution, which was decreased after resuscitation
with minocycline (Figures 2(b)–2(d)). Resuscitation with
minocycline decreased hepatic necrosis from 24.5 ± 1.5%
after vehicle to 8.3 ± 1.4% (P<0.05) (Figure 2(e)). By
contrast,resuscitationwithtetracyclinedidnotdecreaseliver
necrosis after H/R (23.3 ± 1.5 % )i nc o m p a r i s o nt ov e h i c l e
treatment. Overall, minocycline treatment decreased hepatic
necrosis by nearly two-thirds.
3.2.DecreasedLiverApoptosisafterResuscitationwithMinocy-
cline and Tetracycline. TUNEL was performed on tissue
sections to assess double-stranded DNA breaks that are
characteristic of apoptosis. TUNEL-positive parenchymal
cells were rare after sham operation, averaging less than
one cell per high power ﬁeld (HPF). At 6h after H/R with
vehicle, TUNEL of parenchymal cells in nonnecrotic areas
increased to 17.7 ± 3.2cells/HPF (Figure 3). Treatment with
minocycline decreased TUNEL by half to 8.7 ±1.7cells/HPF
(P<0.05 compared to vehicle, Figure 3). After resuscitation
with tetracycline, TUNEL-positive cells in nonnecrotic areas
decreasedto 9±2.2cells/HPF(P<0.05 comparedto vehicle,
Figure 3)a sw e l l .
To further investigate the extent of apoptosis after
minocycline and tetracycline treatment, caspase-3 activity
was measured in liver extracts at 6h after resuscitation
with vehicle, minocycline and tetracycline in comparison to
sham operation (Figure 4). After sham operation, caspase-
3 activity was very low. After H/R with vehicle, caspase-
3 activity increased 8.6-fold, which decreased to 2.8-fold4 HPB Surgery
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Figure 2: Minocycline decreases necrosis after hemorrhage and resuscitation. H/R was performed, as described in Figure 1.N e c r o s i sw a s
assessed by H&E histology at 6h after sham operation (a) or resuscitation with vehicle, minocycline, or tetracycline (b–d). In (e), necrosis as
percent area in liver sections was averaged from 5 livers per treatment group. Necrosis in sham-operated mice was absent and not plotted. ∗,
central vein. Bar is 100µm. ∗P<0.05 versus vehicle and tetracycline.
after minocycline and to 2-fold after tetracycline (P<0.05
compared to vehicle, Figure 4).
3.3. Decreased Oxidative Stress after Resuscitation with
Minocycline. We used 4-HNE immunohistochemistry to
evaluate oxidative stress in livers 6h after hemorrhage and
resuscitation. HNE is an aldehyde product of lipid perox-
idation that forms covalent adducts with proteins that are
recognized by anti-HNE antibodies. After sham operation,
the brown reaction product of HNE immunohistochemistry
was virtually undetectable (Figure 5(a)). By contrast at 6h
after resuscitation with vehicle or tetracycline, wide conﬂu-
ent areas of HNE immunoreactivity developed in pericentralHPB Surgery 5
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Figure 3: Minocycline and tetracycline decrease apoptosis after
hemorrhage and resuscitation. H/R was performed, as described in
Figure 1. Apoptosis of parenchymal cells was assessed by TUNEL
in nonnecrotic areas at 6h after sham operation or resuscitation
with vehicle, minocycline, or tetracycline. The average number of
TUNEL positive cells is plotted for each treatment group. TUNEL
for sham was virtually zero and is not plotted. Bar is 50µm. ∗P<
0.05 versus vehicle.
and midzonal areas with relative sparing the periportal
regions (Figures 5(b) and 5(d)). However, after H/R with
minocycline, HNE immunoreactivity was decreased about
70% compared to vehicle and tetracycline treatments. HNE
staining withminocycline wasconﬁnedmostlytopericentral
regions. (P<0.05 compared to vehicle and tetracycline,
Figures 5(c) and 5(e)).
3.4. Mitochondrial Dysfunction In Vivo after Hemorrhage
and Resuscitation: Protection by Minocycline. At 4h after
sham operation, intravital multiphoton microscopy revealed
bright ﬂuorescence of rhodamine 123 in virtually all hepato-
cytes whose punctate pattern signiﬁed polarization of indi-
vidual mitochondria and normal mitochondrial function
(Figure 6(a)). Cytosolic and nuclear areas had little ﬂuores-
cence. By contrast at 4h after H/R with vehicle treatment,
rhodamine 123 staining became diﬀuse and dim in many
hepatocytes (Figure 6(b)), which indicated mitochondrial
depolarization and dysfunction. Similar to the necrosis and
HNE immunoreactivity that became present at 6h after
H/R (see Figures 2 and 5), mitochondrial depolarization
after 4h had a predominantly pericentral and midzonal
distribution (data not shown). After H/R with minocy-
cline,fewerhepatocytescontaineddepolarizedmitochondria
(Figure 6(c)), whereas mitochondrial depolarization after
tetracycline treatment was indistinguishable from vehicle-
treated liver after H/R (Figure 6(d)). At 4h postoperatively,
livers were scored and counted for rhodamine 123 stain-
ing (Figure 6(e)). In sham-operated mice, 0.05 ± 0.002
hepatocytes/HPF contained depolarized mitochondria. After
H/R with vehicle treatment, 12.2 ± 0.9 hepatocytes/HPF
contained depolarized mitochondria, which corresponded
to depolarization of 57.8 ± 5.2% of hepatocytes. After H/R
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Figure 4: Minocycline and tetracycline decrease caspase 3 activa-
tion after hemorrhage and resuscitation. H/R was performed, as
described in Figure 1, and caspase 3 activity was assessed in liver
homogenates after sham operation or resuscitation with vehicle,
minocycline, or tetracycline. Activity is expressed as fold increase
over sham-operated mice. ∗P<0.05 versus vehicle.
with minocycline treatment, hepatocytes with depolarized
mitochondria decreased to 5.4 ± 0.7 hepatocytes/HPF (P<
0.05 versus vehicle and tetracycline). By contrast, after H/R
with tetracycline, 12.7 ± 0.9 hepatocytes/HPF contained
depolarized mitochondria, which was not diﬀerent from
vehicle treatment (Figure 6(e)).
4. Discussion
Hemorrhage is a risk of trauma and major surgery, partic-
ularly gastrointestinal and hepatobiliary surgery, and tissue
damage after hemorrhage and resuscitation is a variant of
ischemia/reperfusion injury. Despite advances in medical
and surgical treatment, the golden hour for resuscitation
remains a time limit and barrier to eﬀective treatment
of hemorrhagic shock. Moreover, the liver is among the
most frequently aﬀected organs after hemorrhage-induced
hypotension in humans [5]. Here in a mouse model of
H/R, we show that minocycline substantially decreases
hepatic injury after resuscitation following 3h of profound
hemorrhagic hypotension. Speciﬁcally after 3h of hemor-
rhage followed by resuscitation with shed blood and then
lactated Ringers solution, hepatic necrosis, apoptosis, and
enzyme release decreased by 50% or more after minocy-
cline treatment (Figures 1–4). Minocycline also improved
mitochondrialfunctionasassessedbyintravitalmultiphoton
imaging of the ﬂuorescence of the mitochondrial membrane
potential-indicating ﬂuorophore, rhodamine 123 (Figure 6).
Notably, minocycline protected even when used after blood
resuscitation as a component of Ringer’s solution.
Previous studies show cytoprotection by minocycline
in a variety of settings, including rat liver transplantation,
ischemic renal injury, and various injuries to the central6 HPB Surgery
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Figure 5: Minocycline decreases oxidative stress after hemorrhage and resuscitation. H/R was performed, as described in Figure 1,a n d
immunohistochemical staining was performed for 4-HNE adducts at 6h after sham operation (a) or resuscitation with vehicle, minocycline,
or tetracycline (b–d). In (e), HNE staining as percent area in liver sections was averaged from 5 livers per group. HNE in sham-operated
livers was virtually zero and not plotted. Individual group size was 5. Bar is 50 µm. ∗P<0.05 versus vehicle.
nervoussystem[7–12].InourmodelofmouseH/R,minocy-
clineprotectedevenwhenusedlateduringresuscitationafter
the initial blood resuscitation. Hepatic necrosis assessed by
ALT and histology decreased by half at 6h after H/R with
minocycline treatment, and apoptosis assessed by TUNEL
and caspase-3 activity also decreased by more than half
(Figures 1–4). Necrosis represents the predominant mode
of cell death in the setting of hepatic I/R with apoptosis
contributingtoalesserextent[21,22].However,bothmodes
of cell death, namely, apoptosis progressing to necrosis, can
occur through a common mitochondrial pathway involving
the MPT, a phenomenon of necrapoptosis [23–25].HPB Surgery 7
Sham
(a)
Vehicle
(b)
Minocycline
(c)
Tetracycline
(d)
H
e
p
a
t
o
c
y
t
e
s
 
w
i
t
h
 
d
e
p
o
l
a
r
i
z
e
d
m
i
t
o
c
h
o
n
d
r
i
a
 
(
%
)
0
40
80
V
e
h
i
c
l
e
M
i
n
o
c
y
c
l
i
n
e
T
e
t
r
a
c
y
c
l
i
n
e
∗
(e)
Figure 6: Minocycline decreases mitochondrial depolarization after hemorrhage and resuscitation. H/R was performed, as described in
Figure 1, and intravital multiphoton microscopy of rhodamine 123 ﬂuorescence was performed 4 h after sham operation (a) or resuscitation
with vehicle, minocycline, or tetracycline (b–d), as described in materials and methods. Punctate staining of rhodamine 123 denoted
polarization of individual mitochondria, whereas dim diﬀuse cellular staining indicated mitochondrial depolarization. In (e), the average
percentage of hepatocytes with depolarized mitochondria is plotted for each H/R treatment group. Mitochondrial depolarization in sham-
operated livers was virtually zero and not plotted. Size of individual groups was 5. Bar is 30µm. ∗P<0.05 versus vehicle.
After orthotopic rat liver transplantation, minocycline
cytoprotection against hepatic necrosis, apoptosis, and
enzyme release is virtually identical to the cytoprotection
of N-methyl-4-isoleucine cyclosporin (NIM811), a spe-
ciﬁc inhibitor of the MPT [7]. Minocycline also inhibits
calcium-induced MPT onset in isolated mitochondria.
Unlike NIM811 which inhibits the MPT pore component,
cyclophilin D, minocycline prevents MPT onset by blocking
electrogenic calcium uptake by the mitochondrial calcium
uniporter. Since H/R caused mitochondrial depolarization
that was virtually identical to mitochondrial depolarization
after liver transplantation, and since minocycline protected
against this depolarization (Figure 6), it is likely the minocy-
cline protects against hepatic injury after H/R by blocking
MPT onset. Importantly, minocycline-sensitive mitochon-
drial depolarization signifying the MPT preceded necrotic
cell death and thus was not a consequence of cell death, since
after 4h few cells labeled with propidium iodide, a marker
of nonviable cells, as described previously [7]. Tetracycline,
which did not decrease hepatic necrosis and ALT release
after H/R, did not prevent mitochondrial depolarization
after H/R (Figure 6). Because minocycline protected against
mitochondrial depolarization, necrosis, and apoptosis, liver
damage after H/R would appear to be largely a necroapop-
totic phenomenon [26].
Instorage/reperfusioninjuryduringlivertransplantation
and in isolated mitochondria, tetracycline does not protect
against hepatic damage, mitochondrial depolarization, and
onset of the MPT [7]. Similarly in the present work,
tetracycline did not protect against hepatic necrosis, enzyme
release, and mitochondrial depolarization after H/R (Figures
1, 2 and 6). By contrast, tetracycline protected similarly
to minocycline against apoptosis, as assessed by TUNEL
and caspase 3 (Figures 3 and 4). This ﬁnding suggests8 HPB Surgery
diﬀerent protective actions—one unique to minocycline and
another shared by both tetracycline and minocycline. One
shared action is that minocycline and tetracycline are both
calcium chelators [27, 28], although only minocycline blocks
mitochondrial calcium uptake [7]. Thus, suppression of
apoptosis by tetracycline and minocycline might be due to
calcium chelation. Alternatively in necrapoptosis, apoptosis
progresses to necrosis with increasing severity of an inducing
stress.Consequently,protectivestrategiesmayrevertnecrosis
to apoptosis, such that protected necrotic areas begin toshow
apoptosis. Accordingly, protection against apoptosis by an
agent like minocycline may be oﬀs e ti np a r tb yi n c r e a s e d
apoptosis in areas that otherwise would have become
necrotic. Tetracycline, by contrast, did not decrease necrosis,
and tetracycline may simply represent a much weaker pro-
tective agent than minocycline that protects partially against
apoptosis but not at all against necrosis. Future studies will
be needed to distinguish between these possibilities.
In I/R, oxidative stress after reperfusion promotes the
MPT, and antioxidants are protective. After H/R in our
mouse model, 4-HNE immunostaining increased substan-
tially as an indicator of lipid peroxidation and oxidative
stress (Figure 5). Minocycline decreased this 4-HNE staining
after H/R. Since minocycline is not an antioxidant, decreased
HNE staining by minocycline suggests that oxidative stress
is occurring as a consequence of the MPT and cell death.
However, much HNE staining occurred in regions that had
not yet become necrotic, and this oxidative stress might
nonetheless be contributing to the progression of injury.
Endotoxin acting through lipopolysaccharide-binding
protein contributes to H/R injury to liver [15]. As an
antibiotic, minocycline might alter intestinal ﬂora and hence
endotoxemia after H/R. However, tetracycline is also a
broad spectrum antibiotic, and tetracycline did not protect
after H/R. The danger of bacterial infection necessitates
prophylactic use of antibiotics, such as broad spectrum
cephalosporins, after multiple trauma and in advance of
major surgery [29–31]. Since minocycline is a broad spec-
trum antibiotic with an excellent safety record, one-time
treatment of hemorrhagic shock patients with minocycline
would be consistent with current clinical practice and has
the additional beneﬁt of decreasing injury from H/R and
the subsequent development of MODS. Future studies will
be needed to determine what beneﬁt, if any, minocycline
might have in a clinical setting of hemorrhagic shock and
resuscitation.
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4HNE: 4-Hydroxynonenal
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ATP: Adenosine triphosphate
H/R: Hemorrhage and resuscitation
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HPF: High power ﬁeld
MODS: Multiple organ dysfunction syndrome
MPT: Mitochondrial permeability transition
NIM811: N-Methyl-4-isoleucine cyclosporin
PT: Permeability transition
SIRS: Systemic inﬂammatory response syndrome
TUNEL: Terminal deoxynucleotidyl transferase-mediated
dUTP nick-end labeling.
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